>VIVIMED LABS: Acquisition of Uquifa Spain and Uquifa Mexico

SYNOPSIS

■ Vivimed Labs Ltd engages in the specialty chemicals & pharmaceuticals businesses in India.


■ During the quarter ended, the robust growth of revenue is increased by 8.20% to Rs.928.50 million.


■ Vivimed Labs Ltd has acquired Uquifa, a 75-year-old manufacturer of pharma


■ APIs and intermediates with operations in Spain and Mexico.


■ Vivimed has offices in India, China, Europe & USA, with manufacturing facilities focused around Hyderabad city in India.


■ Vivimed Labs has floated three overseas subsidiaries, either directly/ through its subsidiary companies.


■ Net Sales and PAT of the company are expected to grow at a CAGR of 32% and 44% over 2010 to 2013E respectively.


To read full report: VIVIMED LABS
RISH TRADER